Azar targets pharmaceutical industry with drug plan: ‘Something has to change’

Published



Health and Human Services Secretary Alex Azar fired back Friday at drugmakers who labeled him as “un-American” for his new drug price proposal, describing industry resistance as the reason for high U.S. prices.

“Something has to change in how Medicare pays for physician-administered drugs,” Azar said at the Brookings Institution. “The only thing standing in the way is the one special interest that has benefited from this program far out of proportion to any other actor, for the last 15 years: The pharmaceutical industry.”

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.